Quarterly report pursuant to Section 13 or 15(d)

Operating Segments - Schedule of Segment Reporting Information (Details)

v3.10.0.1
Operating Segments - Schedule of Segment Reporting Information (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Revenue from external customers $ 11,984 $ 11,758 $ 37,801 $ 37,179
Intercompany revenues
Gross profit 1,825 1,745 7,189 6,817
Research and development 229 293 680 1,300
Interest income 82 34 212 105
Interest expense (62) (59) (177) (249)
Interest expense-financing fees (10) (9) (27) (27)
Depreciation and amortization 364 1,107 1,095 3,394
Segment income (loss) before income taxes (1,025) (1,906) 86 (3,660)
Income tax (benefit) expense (1,342) 71 (1,272) 218
Segment income (loss) 317 (1,977) 1,358 (3,878)
Expenditures for segment assets 548 84 1,102 200
Treatment [Member]        
Revenue from external customers 9,103 9,355 27,207 29,019
Intercompany revenues 174 77 463 191
Gross profit 1,564 1,613 5,867 6,474
Research and development 126 96 355 339
Interest income
Interest expense (8) (1) (16) (27)
Interest expense-financing fees
Depreciation and amortization 234 964 702 2,960
Segment income (loss) before income taxes 506 40 [1] 4,279 [2] 2,880 [1]
Income tax (benefit) expense (1,342) [3] 70 (1,277) [3] (215)
Segment income (loss) 1,848 (30) 5,556 2,665
Expenditures for segment assets 525 81 1,016 188
Services [Member]        
Revenue from external customers 2,881 2,403 10,594 8,160
Intercompany revenues 16 10 55 21
Gross profit 261 132 1,322 343
Research and development
Interest income
Interest expense (1) (1) (2) (2)
Interest expense-financing fees
Depreciation and amortization 122 134 367 405
Segment income (loss) before income taxes (224) (478) (194) (1,738)
Income tax (benefit) expense
Segment income (loss) (224) (478) (194) (1,738)
Expenditures for segment assets 22 3 82 12
Medical [Member]        
Revenue from external customers
Intercompany revenues
Gross profit
Research and development 88 197 259 947
Interest income
Interest expense
Interest expense-financing fees
Depreciation and amortization
Segment income (loss) before income taxes (88) (197) (259) (947)
Income tax (benefit) expense
Segment income (loss) (88) (197) (259) (947)
Expenditures for segment assets
Segments Total [Member]        
Revenue from external customers 11,984 11,758 37,801 37,179
Intercompany revenues 190 87 518 212
Gross profit 1,825 1,745 7,189 6,817
Research and development 214 293 614 1,286
Interest income
Interest expense (9) (2) (18) (29)
Interest expense-financing fees
Depreciation and amortization 356 1,098 1,069 3,365
Segment income (loss) before income taxes 194 (635) 3,826 195
Income tax (benefit) expense (1,342) 70 (1,277) (215)
Segment income (loss) 1,536 (705) 5,103 (20)
Expenditures for segment assets 547 84 1,098 200
Corporate [Member]        
Revenue from external customers [4]
Intercompany revenues [4]
Gross profit [4]
Research and development [4] 15 66 14
Interest income [4] 82 34 212 105
Interest expense [4] (53) (57) (159) (220)
Interest expense-financing fees [4] (10) (9) (27) (27)
Depreciation and amortization [4] 8 9 26 29
Segment income (loss) before income taxes [4] (1,219) (1,271) (3,740) (3,855)
Income tax (benefit) expense [4] 1 5 3
Segment income (loss) [4] (1,219) (1,272) (3,745) (3,858)
Expenditures for segment assets [4] $ 1 $ 4
[1] Amounts include tangible asset impairment loss of $672,000 for the Company's M&EC subsidiary.
[2] Amounts included a net gain of $1,596,000 recorded resulting from the exchange offer of the Series B Preferred Stock of our M&EC subsidiary (see "Note 13 - M&EC Series B Preferred Stock" below).
[3] Amounts included a tax benefit recorded in the amount of approximately $1,380,000 during the third quarter. (see "Note 12 - Income Taxes" below).
[4] Amounts reflect the activity for corporate headquarters not included in the segment information.